Biodesix (BDSX) Share-based Compensation (2019 - 2026)

Biodesix (BDSX) has 8 years of Share-based Compensation data on file, last reported at $59000.0 in Q1 2026.

• Quarterly Share-based Compensation fell 93.93% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$269000.0 (down 102.67% YoY) and the FY2025 annual result came in at $644000.0, down 90.3% from the prior year.
• Share-based Compensation grew to $59000.0 in Q1 2026, from -$88000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $6.4 million in Q4 2024 to a low of -$1.3 million in Q3 2025.
• A 5-year average of $1.5 million and a median of $1.2 million in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2023 — Share-based Compensation jumped 8565.38% — and 2025, when it tumbled 184.42%.
• Tracing BDSX's Share-based Compensation over 5 years: stood at $52000.0 in 2022, then jumped by 8565.38% to $4.5 million in 2023, then surged by 41.08% to $6.4 million in 2024, then slumped by 101.38% to -$88000.0 in 2025, then jumped by 167.05% to $59000.0 in 2026.
• The last three Share-based Compensation figures came in at $59000.0 (Q1 2026), -$88000.0 (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.